The clinical landscape in Great Britain is witnessing a fundamental shift toward "Theranostics," a practice where the same isotope-targeting molecule is used for both diagnosis and therapy. The latest UK Radiopharmaceuticals Market analysis highlights how this approach is revolutionizing the treatment of prostate cancer and neuroendocrine tumors. By utilizing PET/CT imaging to visualize exactly...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai 
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china